软件工程师/Software Engineer
安序源生物科技（苏州）有限公司/Anxuyuan Biotechnology (Suzhou) Co.,Ltd.
职位信息 / JOB DESCIPTION
Development and verification of biological/gene detection system;
Responsible for the development of software related to biological/gene testing instruments, who can independently complete software development, integration and testing;
job requirements:
Full-time 985/211 bachelor degree or above, three years of embedded microcontroller and WINDOWS software development experience or above, under 35 years old;
Computer, software, electronics and other science and engineering related majors, with system planning and image processing software design capabilities;
Familiar with software development tools, capable of independent development and system integration testers;
Those who are familiar with or have experience in RT-qPCR instrument development are preferred.
Responsible for the development of software related to biological/gene testing instruments, who can independently complete software development, integration and testing;
job requirements:
Full-time 985/211 bachelor degree or above, three years of embedded microcontroller and WINDOWS software development experience or above, under 35 years old;
Computer, software, electronics and other science and engineering related majors, with system planning and image processing software design capabilities;
Familiar with software development tools, capable of independent development and system integration testers;
Those who are familiar with or have experience in RT-qPCR instrument development are preferred.
联系方式 / CONTACT
ADD: Unit 301 BldgB9, Phase I, Biopharmaceutical Industry Park ,218 Xinghu Street, Suzhou Industrial Park
E-MAIL：xudq@axbio.cn
E-MAIL：xudq@axbio.cn
公司信息 / PROFILE
Anxuyuan founded on April 7, 2020, it is a wholly-owned subsidiary of AXBIO.INC in the United States. American AXBIO.INC company was founded by a number of Silicon Valley serial entrepreneurs, multinational group executives, senior engineers and scientists. Its professional fields cover chip development, nanotechnology, microfluidics, biotechnology, bioinformatics, big data, artificial intelligence, etc. , And received capital injection from the world's top venture capital institutions. The company successfully developed a microfluidic Bio-CMOS platform capable of high-throughput sequencing and molecular diagnosis. The versatility of the platform makes it possible to manufacture a wide range of systems, from low-cost handheld devices for bedside diagnostics and consumers to fully automated instruments for use in independent laboratories and hospitals.
